TY - JOUR
T1 - Southwestern Internal Medicine Conference
T2 - Pneumonias in adults due to mycoplasma, chlamydiae, and viruses
AU - Luby, J. P.
PY - 1987
Y1 - 1987
N2 - Pneumonias in adults due to mycoplasma, chlamydiae, and viruses are a common clinical problem. These microorganisms cntribute to the etiologies in 6-35% of all cases of pneumonia and are the sole pathogens in 1-17% of hospitalized cases. Important trends and developments in the field include (1) the emergence of a Chlamydia psittaci strain (TWAR) that is passaged from human to human, causes a mycoplasma-like illness, and that is relatively resistant to erythromycin, (2) the recognition of respiratory syncytial virus as a pathogen in nursing home outbreaks and in immunosuppressed adults, (3) the continuing high lethality of fully developed influenza pneumonia, (4) the efficacy of acyclovir and adenine arabinoside in limiting the complications of varicella-zoster virus infections, and (5) the increasing frequency of pneumonia caused by cytomegalovirus and the severity of this disorder in highly immunosuppressed patients. Developments in the rapid diagnosis and therapy of respiratory syncytial virus infections with an aerosolized antiviral drug in children may pave the way for comparable advances in difficult pneumonias in adult patients.
AB - Pneumonias in adults due to mycoplasma, chlamydiae, and viruses are a common clinical problem. These microorganisms cntribute to the etiologies in 6-35% of all cases of pneumonia and are the sole pathogens in 1-17% of hospitalized cases. Important trends and developments in the field include (1) the emergence of a Chlamydia psittaci strain (TWAR) that is passaged from human to human, causes a mycoplasma-like illness, and that is relatively resistant to erythromycin, (2) the recognition of respiratory syncytial virus as a pathogen in nursing home outbreaks and in immunosuppressed adults, (3) the continuing high lethality of fully developed influenza pneumonia, (4) the efficacy of acyclovir and adenine arabinoside in limiting the complications of varicella-zoster virus infections, and (5) the increasing frequency of pneumonia caused by cytomegalovirus and the severity of this disorder in highly immunosuppressed patients. Developments in the rapid diagnosis and therapy of respiratory syncytial virus infections with an aerosolized antiviral drug in children may pave the way for comparable advances in difficult pneumonias in adult patients.
UR - http://www.scopus.com/inward/record.url?scp=0023254724&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023254724&partnerID=8YFLogxK
U2 - 10.1097/00000441-198707000-00007
DO - 10.1097/00000441-198707000-00007
M3 - Article
C2 - 3037901
AN - SCOPUS:0023254724
SN - 0002-9629
VL - 294
SP - 45
EP - 64
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
IS - 1
ER -